secwatch.observer — SEC 8-K summary
======================================

Issuer:     Fortress Biotech, Inc. (FBIO)
CIK:        0001429260
Form:       8-K
Filed at:   2023-05-05T23:59:59+00:00
Accession:  0001558370-23-008300
Event type: regulatory
Sentiment:  negative
Materiality: 0.65
Item codes: 3.01
LLM model:  deepseek-v4-flash:cloud@v2

Fortress Biotech gets second 180-day Nasdaq bid-price compliance extension to Oct 30, 2023
--------------------------------------------------------------------------------

- Nasdaq granted second 180-day grace period under Listing Rule 5810(c)(3)(A)(ii) on May 2, 2023.
- Company must demonstrate closing bid above $1.00 for 10 consecutive days by October 30, 2023.
- If noncompliant by deadline, Nasdaq will issue delisting notice; company may appeal to Hearings Panel.
- Common stock (FBIO) and preferred stock (FBIOP) continue trading on Nasdaq Capital Market.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023008300/0001558370-23-008300-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1429260/000155837023008300/fbio-20230502x8k.htm
  HTML page:      https://secwatch.observer/filing/0001558370-23-008300

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer